Exact Mass: 488.16586980000005
Exact Mass Matches: 488.16586980000005
Found 254 metabolites which its exact mass value is equals to given mass value 488.16586980000005,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
DTXSID60975124
C14H29N6O11P (488.16318540000003)
Dracorubin
A proanthocyanidin isolated from Dracaena draco.
beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp
3-Fucosyllactose
3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696). Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. (PMID 10837303). 3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696)
2-Fucosyllactose
2-Fucosyllactose (Fuc-a( 1->2)Galb(1->4)Glc) is an oligosaccharide first found in milk in the 1950s, and a well established isolation technique was found in 1972 (PMID: 5012321). It has been used as an acceptor substrate in assays of the blood group A and B gene specified glycosyltransferases since. (PMID 6894927). 2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines[1][2].
Egonol glucoside
C25H28O10 (488.16823880000004)
Egonol glucoside is found in mushrooms. Egonol glucoside is produced by Laetiporus sulphureus var. miniatu Production by Laetiporus sulphureus variety miniatus. Egonol glucoside is found in mushrooms.
B-Trisaccharide
B-Trisaccharide in blood group B is formed and excreated due to given Galactose. The B-trisaccharide is the only oligosaccharide detected in plasma after oral galactose administration to a blood-group-B secretor individual. The concentration was 0.38 mg/l of plasma.(PMID: 510288). B-Trisaccharide in blood group B is formed and excreated due to given Galactose.
Fucosyllactose
Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750) [HMDB] Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750).
Blood group B trisaccharide
3,4-di-O-[3-(4-hydroxyphenyl)propionyl]-1,5-dihydroxycyclohexanecarboxylic acid
C25H28O10 (488.16823880000004)
4-O-(beta-D-Glucopyranosyl)-3-O-(D-galactopyranosyl)-L-fucose
alpha-L-rhamnopyranosyl(1->4)-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside
3,5-di-O-[3-(4-hydroxyphenyl)propionyl]-1,4-dihydroxycyclohexanecarboxylic acid
C25H28O10 (488.16823880000004)
beta-D-Mannopyranosyl-(1鈥樏傗垎4)-alpha-D-galactopyranosyl-(1鈥樏傗垎4)-L-rhamnose
(2S)-5,7-dihydroxy-6,8-dimethyldihydroflavone-7-O-(6-O-acetyl)-beta-D-glucopyranoside
C25H28O10 (488.16823880000004)
alphaalpha-D-Glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?2)-L-rhamnose
Cys Glu His Thr
Cys Glu Thr His
Cys Phe Gly Tyr
C23H28N4O6S (488.17294680000003)
Cys Phe Tyr Gly
C23H28N4O6S (488.17294680000003)
Cys Gly Phe Tyr
C23H28N4O6S (488.17294680000003)
Cys Gly Tyr Phe
C23H28N4O6S (488.17294680000003)
Cys His Glu Thr
Cys His Thr Glu
Cys Thr Glu His
Cys Thr His Glu
Cys Tyr Phe Gly
C23H28N4O6S (488.17294680000003)
Cys Tyr Gly Phe
C23H28N4O6S (488.17294680000003)
Asp Glu Glu Pro
Asp Glu Pro Glu
Asp His Met Ser
Asp His Ser Met
Asp Met His Ser
Asp Met Ser His
Asp Pro Glu Glu
Asp Ser His Met
Asp Ser Met His
Glu Cys His Thr
Glu Cys Thr His
Glu Asp Glu Pro
Glu Asp Pro Glu
Glu Glu Asp Pro
Glu Glu Pro Asp
Glu His Cys Thr
Glu His Thr Cys
Glu Pro Asp Glu
Glu Pro Glu Asp
Glu Thr Cys His
Glu Thr His Cys
Phe Cys Gly Tyr
C23H28N4O6S (488.17294680000003)
Phe Cys Tyr Gly
C23H28N4O6S (488.17294680000003)
Phe Gly Cys Tyr
C23H28N4O6S (488.17294680000003)
Phe Gly Tyr Cys
C23H28N4O6S (488.17294680000003)
Phe Tyr Cys Gly
C23H28N4O6S (488.17294680000003)
Phe Tyr Gly Cys
C23H28N4O6S (488.17294680000003)
Gly Cys Phe Tyr
C23H28N4O6S (488.17294680000003)
Gly Cys Tyr Phe
C23H28N4O6S (488.17294680000003)
Gly Phe Cys Tyr
C23H28N4O6S (488.17294680000003)
Gly Phe Tyr Cys
C23H28N4O6S (488.17294680000003)
Gly Tyr Cys Phe
C23H28N4O6S (488.17294680000003)
Gly Tyr Phe Cys
C23H28N4O6S (488.17294680000003)
His Cys Glu Thr
His Cys Thr Glu
His Asp Met Ser
His Asp Ser Met
His Glu Cys Thr
His Glu Thr Cys
His Met Asp Ser
His Met Ser Asp
His Ser Asp Met
His Ser Met Asp
His Thr Cys Glu
His Thr Glu Cys
Met Asp His Ser
Met Asp Ser His
Met His Asp Ser
Met His Ser Asp
Met Ser Asp His
Met Ser His Asp
Pro Asp Glu Glu
Pro Glu Asp Glu
Pro Glu Glu Asp
Ser Asp His Met
Ser Asp Met His
Ser His Asp Met
Ser His Met Asp
Ser Met Asp His
Ser Met His Asp
Thr Cys Glu His
Thr Cys His Glu
Thr Glu Cys His
Thr Glu His Cys
Thr His Cys Glu
Thr His Glu Cys
Tyr Cys Phe Gly
C23H28N4O6S (488.17294680000003)
Tyr Cys Gly Phe
C23H28N4O6S (488.17294680000003)
Tyr Phe Cys Gly
C23H28N4O6S (488.17294680000003)
Tyr Phe Gly Cys
C23H28N4O6S (488.17294680000003)
Tyr Gly Cys Phe
C23H28N4O6S (488.17294680000003)
Tyr Gly Phe Cys
C23H28N4O6S (488.17294680000003)
3-Fucosyllactose
A trisaccharide that is lactose in which the hydroxy group at position 3 of the glucosyl moiety has undergone formal condensation with the anomeric hydroxy group of fucose (6-deoxy-L-galactose) to give the corresponding glycoside. Found in human milk.
2-Fucosyllactose
2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines[1][2].
B-Trisaccharide
Egonol glucoside
C25H28O10 (488.16823880000004)
4-NITROPHENYL 2-ACETAMIDO-2-DEOXY--4-O-A-L-FUCOPYRANOSYL)-B-D-GLUCOPYRANOSIDE
5-(2-carboxyphenyl)-5-hydroxy-1-((2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)-methyl)-3-phenyl-2-pyrrolin-4-one, potassium salt
alpha-D-Galp-(1->4)-beta-D-Galp-O(CH2)2S(CH2)2CO2Me
A glycoside that consists of alpha-D-galactosyl-(1->4)-beta-D-galactose having a 2-(2-methoxycarbonylethylthio)ethyl (CETE) moiety attached to the reducing end anomeric centre.
O-1,4-alpha-L-Dihydrostreptosyl-streptidine 6-phosphate
C14H29N6O11P (488.16318540000003)
alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl(1->2)]-D-galactose
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-beta-D-galactose
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-beta-D-Glcp
6-deoxy-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
(2S,3S,4R,5S,6S)-2-[(2R,3R,4R,5R,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-methyloxane-3,4,5-triol
beta-L-rhamnosyl-(1->4)-beta-D-glucosyl-(1->4)-beta-D-galactose
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]benzenesulfonamide
C24H28N2O7S (488.16171380000003)
4-deoxy-beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranose
beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranosyl-(1->2)-4-deoxy-beta-D-mannopyranose
alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->4)-alpha-D-Glcp
3,4,5-trihydroxy-6-[4-[(E)-2-[2,3,5-trihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]ethenyl]phenoxy]oxane-2-carboxylic acid
C25H28O10 (488.16823880000004)
6-[4-[(E)-2-[3,5-dihydroxy-4-[(E)-3-hydroxy-3-methylbut-1-enyl]phenyl]ethenyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C25H28O10 (488.16823880000004)
3,4,5-trihydroxy-6-[3-hydroxy-2-[(E)-4-hydroxy-3-methylbut-1-enyl]-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]oxane-2-carboxylic acid
C25H28O10 (488.16823880000004)
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] hexanoate
C18H33O13P (488.16586980000005)
[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] pentanoate
C18H33O13P (488.16586980000005)
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] heptanoate
C18H33O13P (488.16586980000005)
Dihydrostreptosyl streptidine 6-phosphate
C14H29N6O11P (488.16318540000003)
egonol beta-D-glucoside
C25H28O10 (488.16823880000004)
A beta-D-glucoside that is egonol in which the hydroxy hydrogen has been replaced by a beta-D-glucosyl residue.
(1s,2r,3r,4r,7r,12s,13r,14r,15s,17r,19s,20r)-15-(furan-3-yl)-3,4,13,20-tetrahydroxy-2,7,14,20-tetramethyl-6,11,18-trioxahexacyclo[10.8.0.0²,¹⁰.0³,⁷.0¹⁴,¹⁹.0¹⁷,¹⁹]icos-9-ene-5,8-dione
C25H28O10 (488.16823880000004)
11-ethylidene-7-hydroxy-7,14-dimethyl-2-methylidene-3,12-dioxo-4,13,17-trioxatetracyclo[8.6.1.0¹,⁵.0¹⁰,¹⁴]heptadec-5-en-16-yl 2-[(acetyloxy)methyl]prop-2-enoate
C25H28O10 (488.16823880000004)
11-{1-chloro-1,6,6-trimethyl-8-oxo-2,7-dioxaspiro[4.5]dec-9-en-3-yl}-6-(furan-3-yl)-7,11-dimethyl-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-4-one
[(2r,3s)-6-[3-(acetyloxy)prop-1-en-1-yl]-2,3-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-4h-1-benzopyran-3-yl]methyl acetate
C25H28O10 (488.16823880000004)
methyl 2-[(2r,4r,6s,10s,12s,13s)-10,13-bis(acetyloxy)-4,15-dimethyl-8-oxo-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-12-yl]prop-2-enoate
C25H28O10 (488.16823880000004)
5-[3''-β-d-glucopyranosyloxy)propyl]-7-me-thoxy-2-(3',4'-methylenedioxyphenyl)benzo-furan
C25H28O10 (488.16823880000004)
{"Ingredient_id": "HBIN011006","Ingredient_name": "5-[3''-\u03b2-d-glucopyranosyloxy)propyl]-7-me-thoxy-2-(3',4'-methylenedioxyphenyl)benzo-furan","Alias": "NA","Ingredient_formula": "C25H28O10","Ingredient_Smile": "COC1=C2C(=CC(=C1)CCCOC3C(C(C(C(O3)CO)O)O)O)C=C(O2)C4=CC5=C(C=C4)OCO5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8708","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-hydroxy-2-methyl-4'-[2-(2-methylpropanoyl)-4-oxoquinazolin-3-yl]-2,9a-dihydrospiro[imidazo[1,2-a]indole-9,2'-oxolane]-3,5'-dione
(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol
(1s,5e,7r,10r,11z,14r,16s)-11-ethylidene-7-hydroxy-7,14-dimethyl-2-methylidene-3,12-dioxo-4,13,17-trioxatetracyclo[8.6.1.0¹,⁵.0¹⁰,¹⁴]heptadec-5-en-16-yl 2-[(acetyloxy)methyl]prop-2-enoate
C25H28O10 (488.16823880000004)
1,3-dihydroxy-4,5-bis({[3-(4-hydroxyphenyl)propanoyl]oxy})cyclohexane-1-carboxylic acid
C25H28O10 (488.16823880000004)
(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol
(2r,3r,4s,5r,6r)-2-{3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
C25H28O10 (488.16823880000004)
methyl (2's,13's,15's,25'r)-15'-hydroxy-2'-methoxy-11',23'-dioxo-1',4',12',22'-tetraazaspiro[cyclopropane-1,24'-hexacyclo[13.9.1.0³,¹².0⁵,¹⁰.0¹⁶,²¹.0²²,²⁵]pentacosane]-3',5',7',9',16',18',20'-heptaene-13'-carboxylate
methyl 2-[(2s,4r,6s,10r,12s,13s)-10,13-bis(acetyloxy)-4,15-dimethyl-8-oxo-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-12-yl]prop-2-enoate
C25H28O10 (488.16823880000004)
methyl (2r,4ar,5s,5'z,8's,8ar)-5,8'-dihydroxy-5'-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1',8'-dimethyl-3,6',7'-trioxo-4a,5,6,8a-tetrahydrospiro[1,4-benzodioxine-2,2'-bicyclo[2.2.2]octane]-7-carboxylate
C25H28O10 (488.16823880000004)
methyl 2-[(2r,4r,6r,10s,12r,13r)-10,13-bis(acetyloxy)-4,15-dimethyl-8-oxo-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-12-yl]prop-2-enoate
C25H28O10 (488.16823880000004)
methyl (2r,4ar,5s,5'z,8's,8ar)-5,8'-dihydroxy-5'-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1',8'-dimethyl-3,6',7'-trioxo-4a,5,8,8a-tetrahydrospiro[1,4-benzodioxine-2,2'-bicyclo[2.2.2]octane]-7-carboxylate
C25H28O10 (488.16823880000004)
(1s,3s,4s,5s)-1,4-dihydroxy-3,5-bis({[3-(4-hydroxyphenyl)propanoyl]oxy})cyclohexane-1-carboxylic acid
C25H28O10 (488.16823880000004)
6-({[3,4-dihydroxy-6-(hydroxymethyl)-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol
(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol
(2s,4r,11r,12e)-7-acetyl-16-[(acetyloxy)methyl]-11-hydroxy-4,11-dimethyl-6,15-dioxo-5,14-dioxatricyclo[11.3.0.0⁴,⁸]hexadeca-1(16),7,12-trien-2-yl 2-methylprop-2-enoate
C25H28O10 (488.16823880000004)
2-[(2,3-dihydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3-{[3-formyl-2,4,6-trihydroxy-5-(3-methylbutanoyl)phenyl]methyl}-2,4,6-trihydroxy-5-(3-methylbutanoyl)benzaldehyde
C25H28O10 (488.16823880000004)
(1r,3s,4r,5r)-1,3-dihydroxy-4,5-bis({[3-(4-hydroxyphenyl)propanoyl]oxy})cyclohexane-1-carboxylic acid
C25H28O10 (488.16823880000004)
2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
(1s,2r,4r,11r,13s)-8-acetyl-15-[(acetyloxy)methyl]-4,11-dimethyl-9,16-dioxo-3,10,17-trioxatetracyclo[12.3.0.0²,⁴.0⁷,¹¹]heptadeca-7,14-dien-13-yl 2-methylprop-2-enoate
C25H28O10 (488.16823880000004)
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[2-methoxy-4-(prop-2-en-1-yl)phenoxy]oxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
C25H28O10 (488.16823880000004)
methyl 2-[10,13-bis(acetyloxy)-4,15-dimethyl-8-oxo-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-12-yl]prop-2-enoate
C25H28O10 (488.16823880000004)
methyl 15'-hydroxy-2'-methoxy-11',23'-dioxo-1',4',12',22'-tetraazaspiro[cyclopropane-1,24'-hexacyclo[13.9.1.0³,¹².0⁵,¹⁰.0¹⁶,²¹.0²²,²⁵]pentacosane]-3',5',7',9',16',18',20'-heptaene-13'-carboxylate
7-acetyl-16-[(acetyloxy)methyl]-11-hydroxy-4,11-dimethyl-6,15-dioxo-5,14-dioxatricyclo[11.3.0.0⁴,⁸]hexadeca-1(16),7,12-trien-2-yl 2-methylprop-2-enoate
C25H28O10 (488.16823880000004)
(2s,3s,4r,5s,6s)-2-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
{4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]-2-oxooxolan-3-yl}(3,4,5-trimethoxyphenyl)methyl acetate
C25H28O10 (488.16823880000004)
methyl 2-[(2s,4r,6s,10r,13s)-10,13-bis(acetyloxy)-4,15-dimethyl-8-oxo-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-12-yl]prop-2-enoate
C25H28O10 (488.16823880000004)
1,4-dihydroxy-3,5-bis({[3-(4-hydroxyphenyl)propanoyl]oxy})cyclohexane-1-carboxylic acid
C25H28O10 (488.16823880000004)
(r)-[(3s,4r)-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]-2-oxooxolan-3-yl](3,4,5-trimethoxyphenyl)methyl acetate
C25H28O10 (488.16823880000004)
(2r,4's,9r,9ar)-1-hydroxy-2-methyl-4'-[2-(2-methylpropanoyl)-4-oxoquinazolin-3-yl]-2,9a-dihydrospiro[imidazo[1,2-a]indole-9,2'-oxolane]-3,5'-dione
(2r,3r,4s,5s,6r)-2-{3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
C25H28O10 (488.16823880000004)
(2e)-3-[(2r,3s)-3-[(acetyloxy)methyl]-2,3-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-4h-1-benzopyran-6-yl]prop-2-en-1-yl acetate
C25H28O10 (488.16823880000004)
(2s,3r,4s,5r,6r)-2-{[(2s,3s,4s,5r,6s)-2,3-dihydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-acetyl-15-[(acetyloxy)methyl]-4,11-dimethyl-9,16-dioxo-3,10,17-trioxatetracyclo[12.3.0.0²,⁴.0⁷,¹¹]heptadeca-7,14-dien-13-yl 2-methylprop-2-enoate
C25H28O10 (488.16823880000004)